Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)
NCT02016183 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3222
Last updated 2018-11-09
Summary
The purpose of this study is to evaluate the safety and efficacy of long-term use of candesartan cilexetil / hydrochlorothiazide combination tablets (ECARD) Combination Tablets LD\&HD in hypertensive patients in the routine clinical setting
Conditions
Interventions
- DRUG
-
Candesartan cilexetil / hydrochlorothiazide
Candesartan cilexetil / hydrochlorothiazide combination tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-01
- Primary Completion
- 2012-09-30
- Completion
- 2012-09-30
Countries
- Japan
Study Locations
More Related Trials
-
Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
NCT02211638 ·Status: COMPLETED
-
Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
NCT02521233 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control
NCT02521246 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension
NCT02059616 ·Status: UNKNOWN ·Phase: PHASE2
-
Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"
NCT02068495 ·Status: COMPLETED
-
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
NCT00434967 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease
NCT01309828 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.
NCT00775814 ·Status: COMPLETED ·Phase: PHASE4
-
High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
NCT00242346 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension
NCT02176850 ·Status: COMPLETED
-
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets
NCT03847506 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
NCT00573742 ·Status: COMPLETED
-
Micardis®. Observational Study in Patients With Essential Hypertension
NCT02200094 ·Status: COMPLETED
-
Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
NCT00282178 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
NCT01289132 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension
NCT00867490 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
NCT00996281 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
NCT00386607 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
NCT02006602 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy
NCT02368652 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
NCT00280540 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension
NCT01303783 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine
NCT00219154 ·Status: COMPLETED ·Phase: PHASE3
-
COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus
NCT00526279 ·Status: COMPLETED
-
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
NCT00818883 ·Status: COMPLETED ·Phase: PHASE3